$ELOX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Eloxx Pharmaceuticals, Inc.. Get notifications about new insider transactions in Eloxx Pharmaceuticals, Inc. for free.
Page: < prev 1 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 27 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Grant | A | 0.51 | 6,016 | 3,089 | 500,165 | 494.1 K to 500.2 K (+1.22 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Grant | A | 0.37 | 14,029 | 5,153 | 494,149 | 480.1 K to 494.1 K (+2.92 %) |
May 24 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | M | 0.01 | 2,000 | 20 | 70,559 | |
May 24 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.61 | 30,000 | 18,300 | 469,569 | |
May 24 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.61 | 11,066 | 6,750 | 439,569 | |
May 24 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.01 | 2,000 | 20 | 55,167 | 53.2 K to 55.2 K (+3.76 %) |
May 24 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.67 | 19,262 | 12,906 | 478,211 | |
May 24 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.61 | 13,934 | 8,500 | 371,205 | |
May 24 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.61 | 22,951 | 14,000 | 263,958 | |
May 24 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.61 | 11,066 | 6,750 | 452,646 | |
May 24 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.61 | 20,082 | 12,250 | 909,951 | |
May 24 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | A | 0.61 | 75,000 | 45,750 | 378,032 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.83 | 87,313 | 72,470 | 542,333 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.83 | 130,969 | 108,704 | 455,020 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 1.01 | 87,313 | 88,186 | 324,051 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 1.01 | 130,969 | 132,279 | 236,738 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 1.01 | 78,581 | 79,367 | 105,769 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.00 | 135,779 | 0 | 150,779 | 15 K to 150.8 K (+905.19 %) |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP - Research and D ... | Option Exercise | A | 0.29 | 300,000 | 87,000 | 807,924 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Option Exercise | A | 0.29 | 300,000 | 87,000 | 457,500 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.29 | 43,334 | 12,567 | 357,271 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.32 | 54,166 | 17,333 | 458,949 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.29 | 77,500 | 22,475 | 241,007 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.29 | 50,834 | 14,742 | 441,580 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.29 | 56,666 | 16,433 | 889,869 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.29 | 50,834 | 14,742 | 428,503 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.29 | 15,000 | 4,350 | 377,669 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | P | 0.83 | 4,213 | 3,497 | 26,872 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | P | 0.83 | 6,320 | 5,246 | 22,659 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | P | 1.01 | 4,213 | 4,255 | 16,339 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | P | 1.01 | 6,320 | 6,383 | 12,126 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | P | 1.01 | 3,792 | 3,830 | 5,806 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Buy | P | 0.00 | 6,552 | 0 | 7,663 | 1.1 K to 7.7 K (+589.74 %) |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | A | 0.29 | 29,166 | 8,458 | 303,032 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | A | 0.29 | 37,500 | 10,875 | 273,866 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | P | 0.83 | 87,313 | 72,470 | 589,062 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | P | 0.83 | 130,969 | 108,704 | 501,749 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | P | 1.01 | 87,313 | 88,186 | 370,780 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | P | 1.01 | 130,969 | 132,279 | 283,467 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | P | 1.01 | 78,581 | 79,367 | 152,498 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Buy | P | 0.00 | 135,779 | 0 | 382,549 | 246.8 K to 382.5 K (+55.02 %) |
Feb 23 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | P | 0.83 | 22,004 | 18,263 | 137,865 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | P | 0.83 | 33,006 | 27,395 | 115,861 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | P | 1.01 | 22,004 | 22,224 | 82,855 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | P | 1.01 | 33,006 | 33,336 | 60,851 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | P | 1.01 | 19,803 | 20,001 | 27,845 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.00 | 34,218 | 0 | 61,551 | 27.3 K to 61.6 K (+125.19 %) |
Feb 23 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | P | 0.83 | 43,539 | 36,137 | 403,428 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | P | 0.83 | 65,309 | 54,206 | 359,889 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | P | 1.01 | 43,539 | 43,974 | 294,580 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | P | 1.01 | 65,309 | 65,962 | 251,041 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | P | 1.01 | 39,185 | 39,577 | 185,732 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Buy | P | 0.00 | 67,707 | 0 | 480,120 | 412.4 K to 480.1 K (+16.42 %) |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Option Exercise | P | 0.83 | 10,768 | 8,937 | 67,559 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Option Exercise | P | 0.83 | 16,152 | 13,406 | 56,791 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Option Exercise | P | 1.01 | 10,768 | 10,876 | 40,639 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Option Exercise | P | 1.01 | 16,152 | 16,314 | 29,871 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Option Exercise | P | 1.01 | 9,691 | 9,788 | 13,719 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Buy | P | 0.00 | 16,745 | 0 | 18,967 | 2.2 K to 19 K (+753.60 %) |
Feb 23 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | P | 0.83 | 567,416 | 470,955 | 3,966,477 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | P | 0.83 | 851,123 | 706,432 | 3,399,061 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | P | 1.01 | 567,416 | 573,090 | 2,547,938 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | P | 1.01 | 851,123 | 859,634 | 1,980,522 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | P | 1.01 | 510,676 | 515,783 | 1,129,399 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.00 | 882,381 | 0 | 3,044,180 | 2.2 M to 3 M (+40.82 %) |
Feb 23 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | P | 0.83 | 10,768 | 8,937 | 72,559 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | P | 0.83 | 16,152 | 13,406 | 61,791 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | P | 1.01 | 10,768 | 10,876 | 45,639 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | P | 1.01 | 16,152 | 16,314 | 34,871 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | P | 1.01 | 9,691 | 9,788 | 18,719 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.00 | 16,745 | 0 | 53,167 | 36.4 K to 53.2 K (+45.97 %) |
Dec 02 2009 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | Sell | S | 0.38 | 21,200 | 7,997 | 98,450 | 119.7 K to 98.5 K (-17.72 %) | |
Dec 02 2009 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | Sell | S | 0.38 | 28,300 | 10,774 | 119,650 | 148 K to 119.7 K (-19.13 %) | |
Nov 25 2009 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | Sell | D | 0.00 | 125,000 | 0 | 106,980 | 232 K to 107 K (-53.88 %) | |
Nov 25 2009 | SVON | Sevion Therapeutic ... | GALTON BRUCE C | Sell | D | 0.00 | 16,500 | 0 | 231,980 | 248.5 K to 232 K (-6.64 %) | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Option Exercise | A | 0.39 | 25,000 | 9,750 | 25,000 | |
Nov 24 2009 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Sell | D | 0.39 | 10,000 | 3,900 | 90,875 | 100.9 K to 90.9 K (-9.91 %) |
Nov 23 2009 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.39 | 50,000 | 19,500 | 390,746 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.39 | 36,539 | 14,250 | 340,746 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.59 | 11,441 | 6,750 | 304,207 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.39 | 70,000 | 27,300 | 163,507 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.39 | 66,923 | 26,100 | 93,507 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.59 | 19,492 | 11,500 | 26,584 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.39 | 25,000 | 9,750 | 313,937 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.39 | 35,898 | 14,000 | 288,937 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.59 | 16,949 | 10,000 | 253,039 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.39 | 70,000 | 27,300 | 833,203 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.39 | 52,949 | 20,650 | 763,203 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.59 | 23,729 | 14,000 | 710,254 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.43 | 40,000 | 17,200 | 404,783 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.43 | 48,718 | 20,949 | 364,783 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.65 | 18,077 | 11,750 | 316,065 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.39 | 50,000 | 19,500 | 362,669 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.39 | 38,462 | 15,000 | 312,669 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.59 | 11,441 | 6,750 | 274,207 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP - Research and D ... | Option Exercise | D | 0.60 | 4,000 | 2,400 | 507,924 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Sell | D | 0.00 | 1,400 | 0 | 100,875 | 102.3 K to 100.9 K (-1.37 %) |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | A | 0.39 | 30,000 | 11,700 | 236,366 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | A | 0.39 | 56,410 | 22,000 | 206,366 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Van Hulst Jack | President and CEO | Option Exercise | A | 0.59 | 20,763 | 12,250 | 149,956 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | FEDYSZYN SASCHA P | VP - Corporate Dev. | Sell | D | 0.00 | 2,100 | 0 | 153,460 | 155.6 K to 153.5 K (-1.35 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.00 | 2,028 | 0 | 9,028 | 7 K to 9 K (+28.97 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.00 | 2,000 | 0 | 7,000 | 5 K to 7 K (+40.00 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.90 | 2,222 | 2,000 | 36,422 | 34.2 K to 36.4 K (+6.50 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.00 | 89,222 | 0 | 618,723 | 529.5 K to 618.7 K (+16.85 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.00 | 88,000 | 0 | 529,501 | 441.5 K to 529.5 K (+19.93 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.90 | 97,778 | 88,000 | 2,191,799 | 2.1 M to 2.2 M (+4.67 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Buy | P | 0.00 | 2,028 | 0 | 4,028 | 2 K to 4 K (+101.40 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Buy | P | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Buy | P | 0.90 | 2,222 | 2,000 | 2,222 | 0 to 2.2 K |
Jul 31 2009 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Buy | P | 0.00 | 7,097 | 0 | 146,547 | 139.5 K to 146.5 K (+5.09 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Buy | P | 0.00 | 7,000 | 0 | 139,450 | 132.5 K to 139.5 K (+5.29 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Buy | P | 0.90 | 7,778 | 7,000 | 412,413 | 404.6 K to 412.4 K (+1.92 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.00 | 3,042 | 0 | 11,042 | 8 K to 11 K (+38.03 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.00 | 3,000 | 0 | 8,000 | 5 K to 8 K (+60.00 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.90 | 3,333 | 3,000 | 24,333 | 21 K to 24.3 K (+15.87 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Buy | P | 0.00 | 1,014 | 0 | 2,014 | 1,000 to 2 K (+101.40 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Buy | P | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Buy | P | 0.90 | 1,111 | 1,000 | 1,111 | 0 to 1.1 K |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.00 | 13,688 | 0 | 27,188 | 13.5 K to 27.2 K (+101.39 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.00 | 13,500 | 0 | 13,500 | 0 to 13.5 K |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.90 | 15,000 | 13,500 | 15,000 | 0 to 15 K |
Jul 31 2009 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Buy | P | 0.00 | 13,688 | 0 | 73,917 | 60.2 K to 73.9 K (+22.73 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Buy | P | 0.00 | 13,500 | 0 | 60,229 | 46.7 K to 60.2 K (+28.89 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Buy | P | 0.90 | 15,000 | 13,500 | 246,771 | 231.8 K to 246.8 K (+6.47 %) |
Mar 17 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.51 | 200 | 102 | 2,094,021 | 2.1 M to 2.1 M (+0.01 %) |
Mar 17 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.49 | 2,300 | 1,127 | 2,093,821 | 2.1 M to 2.1 M (+0.11 %) |
Mar 17 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.46 | 2,300 | 1,058 | 2,091,521 | 2.1 M to 2.1 M (+0.11 %) |
Mar 16 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.39 | 10,200 | 3,978 | 2,089,221 | 2.1 M to 2.1 M (+0.49 %) |
Mar 16 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.36 | 2,000 | 720 | 2,079,021 | 2.1 M to 2.1 M (+0.10 %) |
Mar 16 2009 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Buy | P | 0.37 | 10,000 | 3,700 | 231,771 | 221.8 K to 231.8 K (+4.51 %) |
Mar 16 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.40 | 4,700 | 1,880 | 34,200 | 29.5 K to 34.2 K (+15.93 %) |
Mar 16 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.39 | 1,000 | 390 | 29,500 | 28.5 K to 29.5 K (+3.51 %) |
Mar 16 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.38 | 1,800 | 684 | 28,500 | 26.7 K to 28.5 K (+6.74 %) |
Mar 16 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.37 | 500 | 185 | 26,700 | 26.2 K to 26.7 K (+1.91 %) |
Mar 16 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.38 | 2,000 | 760 | 26,200 | 24.2 K to 26.2 K (+8.26 %) |
Mar 16 2009 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | P | 0.36 | 1,200 | 432 | 24,200 | 23 K to 24.2 K (+5.22 %) |
Mar 12 2009 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Buy | P | 0.36 | 10,000 | 3,600 | 221,771 | 211.8 K to 221.8 K (+4.72 %) |
Mar 11 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.37 | 2,500 | 925 | 2,077,021 | 2.1 M to 2.1 M (+0.12 %) |
Mar 11 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.38 | 10,000 | 3,800 | 2,074,521 | 2.1 M to 2.1 M (+0.48 %) |
Mar 06 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.40 | 1,000 | 400 | 2,064,521 | 2.1 M to 2.1 M (+0.05 %) |
Mar 06 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.38 | 2,000 | 760 | 2,063,521 | 2.1 M to 2.1 M (+0.10 %) |
Mar 06 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.40 | 5,500 | 2,200 | 2,061,521 | 2.1 M to 2.1 M (+0.27 %) |
Mar 04 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.40 | 1,200 | 480 | 2,056,021 | 2.1 M to 2.1 M (+0.06 %) |
Mar 04 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.39 | 3,000 | 1,170 | 2,054,821 | 2.1 M to 2.1 M (+0.15 %) |
Mar 04 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.37 | 2,800 | 1,036 | 2,051,821 | 2 M to 2.1 M (+0.14 %) |
Mar 02 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.39 | 2,000 | 780 | 2,049,021 | 2 M to 2 M (+0.10 %) |
Mar 02 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.40 | 3,000 | 1,200 | 2,047,021 | 2 M to 2 M (+0.15 %) |
Mar 02 2009 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.40 | 4,000 | 1,600 | 2,044,021 | 2 M to 2 M (+0.20 %) |
Feb 24 2009 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.47 | 12,766 | 6,000 | 292,766 |